Anchor Balloon

Anchor Balloon is an early-stage medical device innovator founded in 2018, targeting a significant unmet need in interventional procedures. The company's core technology is a patented angioplasty balloon with integrated guidewire anchoring, aimed at enhancing the deliverability and control of devices in complex vasculature. While still in development and pre-revenue, the platform addresses a large cardiovascular market opportunity and is led by a founder-CEO with a clinical background, supported by a team of experienced consultants in manufacturing, quality, and regulatory affairs. The company appears to be in a pre-clinical or prototype development stage, building its team and foundational systems.

Novel angioplasty balloon with integrated guidewire anchoring technology designed to improve device stability, pushability, and advancement during vascular interventions.

The angioplasty balloon market is highly competitive, dominated by large players like Boston Scientific, Medtronic, and Abbott, who offer extensive portfolios. Anchor Balloon would compete against specialized balloons for complex lesions (e.g., Shockwave Medical's intravascular lithotripsy) and other guidewire-based support devices. Its success hinges on demonstrating a unique and superior mechanical advantage.